A Roadmap for Introducing Novel Excipients: How to Approach Excipient Qualification with the FDA
The Premier Consulting Blog
NOVEMBER 16, 2022
Although novel excipients can be a part of any new drug application (NDA) or biologics license application (BLA) development program, they seem to be more common with the 505(b)(2) pathway, since many companies use cutting-edge delivery technologies to solve issues associated with previously approved drugs. What is an excipient?
Let's personalize your content